New MRI for metabolic fatty liver disease
Part of Digestive system clinical trials.
This study uses a new MRI technique to measure how metabolic fatty liver disease affects your body and to track your health over time. It aims to improve understanding of the condition and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are suspected or diagnosed with metabolic fatty liver disease
- You have been scheduled for an MRI scan
- You agree to join the study and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with nonalcoholic fatty liver disease to better understand the condition. It uses an MRI scan and collects body samples to help researchers study changes over time.
This study compares new, non-invasive tests to standard liver biopsy for diagnosing fatty liver disease in people with type 2 diabetes or other signs of metabolic syndrome. It aims to see if these simpler tests can replace biopsies.
This trial compares a new ultrasound technique to a standard MRI scan for measuring liver fat. It may help improve how we diagnose and monitor fatty liver disease.
This study tests whether a new type of MRI scan can better detect and measure liver disease, including fatty liver and scarring, compared to standard CT scans. If you have chronic liver disease, this study may help improve how we diagnose and track it.
This study uses advanced MRI scans to get a clearer picture of liver fat, inflammation, and scarring in people with chronic liver disease. It aims to help doctors diagnose and understand liver problems better.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
Hear when a new Non-Alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.